Fungal infections
Conditions
Interventions
Peritoneal cavity group:Routine voriconazole treatment
Pleural cavity group:Routine voriconazole treatment
Pericardial cavity group:Routine voriconazole treatment
Cerebrospinal fluid group :Routine voriconazole treatment
Bile group:Routine voriconazole treatment
Sponsors
The First Affiliated Hospital of Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged >=18 years; 2. Undergoing drainage of peritoneal fluid or pleural fluid or pericardial fluid or cerebrospinal fluid or bile; 3. Receiving intravenous voriconazole.
Exclusion criteria
Exclusion criteria: 1. Concomitant use of strong CYP450 enzyme inhibitors or inducers; 2. Absence of voriconazole concentrations; 3. Absence of important dosing information or clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma voriconazole concentrations;Voriconazole concentrations in peritoneal fluid;Voriconazole concentrations in pleural fluid;Voriconazole concentrations in pericardial fluid;Voriconazole concentrations in cerebrospinal fluid;Voriconazole concentrations in bile;Clinical efficacy/outcomes;Adverse reaction rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical indices; | — |
Countries
China
Contacts
Public ContactCai Changjie
The First Affiliated Hospital of Sun Yat-sen University
Outcome results
None listed